O
AVTR icon

OrbiMed’s Avantor AVTR Stock Holding History

OrbiMed’s Portfolio AVTR Stock Details AVTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,012,800
Closed -$18.4M – 146
2019
Q4 		$18.4M Buy
+1,012,800
New +$16.1M 0.26% 70

Other funds holding AVTR

NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

OrbiMed's AVTR Position: Q1 2020 in Review

OrbiMed sold out of Avantor (AVTR) in Q1 2020, closing a stake of 1,012,800 shares — an estimated $18.4M sold.

OrbiMed first reported a position in AVTR in Q4 2019 and held it in 1 quarter. The position peaked at $18.4M in Q4 2019. 171 funds tracked by Wall St. Rank hold AVTR as of Q1 2020.

  • OrbiMed reported no remaining Avantor position as of Q1 2020 after selling out during the quarter.
  • OrbiMed sold 1,012,800 Avantor shares in Q1 2020, an estimated $18.4M.
  • OrbiMed first reported a position in Avantor in Q4 2019 and held it in 1 quarter.
  • OrbiMed's Avantor position peaked at $18.4M in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Avantor as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.